,,ii #aadth ,,congress #ast ,session ,s4 #ahgh ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,july #bh1 #bjae ,mr4 ,casey 7for himself and ,mr4 ,isakson7 introduced the following bill2 which was read twice and referred to the ,committee on ,health1 ,education1 ,labor1 and ,pensions ,a ,,bill ,to extend the pediatric priority review voucher program4 #a4 ,short title ,this ,act may be cited as the ,advancing ,hope ,act of #bjae4 #b4 ,reauthorization of program for priority review ,to encourage treatments for rare pediatric diseases ,section #ebi of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;ff7 is amended-- 7#a7 in subsection 7a7-- 7,a7 by amending paragraph 7#c7 to read as follows3 7#c7 ,rare pediatric disease ,the term rare pediatric disease means any of the following3 7,a7 ,a disease that meets each of the following criteria3 7i7 ,the disease primarily affects individuals aged from birth to #ah years1 including age groups often called neonates1 infants1 children1 and adolescents4 7ii7 ,the disease is a rare disease or condition1 within the meaning of section #ebf4 7,b7 ,any form of sickle cell disease4 7,c7 ,any pediatric cancers4 2 and 7,b7 in paragraph 7#d7-- 7i7 in subparagraph 7,e71 by striking and at the end2 7ii7 in subparagraph 7,f71 by striking the period at the end and inserting 2 and2 and 7iii7 by adding at the end the following3 7,g7 is for a drug or biological product for which a priority review voucher has not been issued under section #ebd 7relating to tropical disease products74 2 7#b7 in subsection 7b71 by striking paragraph 7#e72 and 7#c7 in subsection 7d77#b71 in the second sentence1 by striking the period and inserting 1 but the sponsor of a drug that intends to request a priority review voucher under this section shall notify the ,secretary of such intent upon submission of an application under section #eje or section #cea of the ,public ,health ,service ,act that is the basis of such request44